Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 23
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
UroGen Pharma Ltd
URGN
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$35.15
-0.33
-0.93%
Dern. MÀJ: Oct 22, 4:00 PM
$35.15
-0.33
-0.93%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
UroGen Pharma Financials
UroGen Pharma (URGN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
UroGen Pharma Q2 EPS $(0.28) Beats $(0.29) Estimate, Sales $72.456M Beat $63.526M Estimate
UroGen Pharma (NASDAQ:URGN) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 73.33 percent increase over losses of $(1.05) per share from the
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
UroGen Pharma Q1 EPS $(0.47) Beats $(0.48) Estimate, Sales $50.959M Beat $44.820M Estimate
UroGen Pharma (NASDAQ:URGN) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 48.91 percent increase over losses of $(0.92) per share from the
Benzinga Newsdesk
UroGen Pharma: Q4 Earnings Insights
Benzinga Insights
PRO
UroGen Pharma Q4 EPS $(0.54) Misses $(0.53) Estimate, Sales $37.837M Miss $39.922M Estimate
Benzinga Newsdesk
Earnings Scheduled For March 2, 2026
Benzinga Insights
